Sanofi-Aventis to Invest in Chinese Vaccine Plant

Sanofi-Aventis plans to build a 70 mln. euro flu vaccine manufacturing plant near Hong Kong, the largest biopharmaceutical investment ever by a foreign drug maker in China, the French company said.
Hemscott